Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster display session

4P - FAT1: A novel modulator of autophagy in human glioblastoma

Date

21 Mar 2023

Session

Poster display session

Presenters

Yakhlesh Gupta

Citation

Annals of Oncology (2023) 8 (1suppl_3): 101012-101012. 10.1016/esmoop/esmoop101012

Authors

Y. Gupta1, N. Malik1, S. Goswami1, M. Arora1, A. Kundu1, S. Gupta1, M. Kapoor1, V. Suri2, A. Suri3, P. Chattopadhyay1, S. Sinha1, K. Chosdol1

Author affiliations

  • 1 Biochemistry, AIIMS - All India Institute of Medical Sciences, 110029 - New Delhi/IN
  • 2 Neuropathology, AIIMS - All India Institute of Medical Sciences, 110029 - New Delhi/IN
  • 3 Neurosurgery, AIIMS - All India Institute of Medical Sciences, 110029 - New Delhi/IN

Resources

This content is available to ESMO members and event participants.

Abstract 4P

Background

Glioblastoma, lethal brain tumor arising from glial cells. Our lab, have identified the oncogenic role of FAT1 gene in glioblastoma, regulating inflammatory, hypoxic microenvironment and migratory/invasive properties of the tumor cells. The elimination of cancer cells may also be mediated by autophagic cell death. Here we have established the effect of FAT1 on cellular autophagy and cancer cell death.

Methods

Glioblastoma cells U87MG and LN229 were cultured under normoxia & hypoxia. FAT1 was knocked out by CRISPR Cas9. Cell death were analyzed by MTT assay. Expression of autophagy markers were analyzed by qPCR & Westernblot. Modulation of autophagy was done by EBSS and Bafilomycin. Subcellular expression of autophagy marker was analyzed using confocal microscopy. Expression correlation was done in Glioblastoma patient tumor samples (n=30) collected from Neurosurgery OT, AIIMS, by qPCR and IHC.

Results

FAT1 (∼500kDa protien) was knocked out successfully with ∼95% efficiency in U87MG and LN229 cells. We observed significant cell death with deprived serum condition in FAT1 knockout cells. Expression of autophagy markers (Beclin1, LC3b, ULK1, ATG13, ATG7 and ATG5) found significantly increased at mRNA and protein level in FAT1 knockout cells. On autophagy modulation we found further increased in expression of autophagy markers at mRNA and protein level in FAT1 knockout cells, as well as significantly increased subcellular expression of LC3b was observed. There was significant negative correlation between the expression of FAT1 and autophagy markers were observed in Glioblastoma patient tumor samples.

Conclusions

On FAT1 knockout, under tumor mimic conditions (serum-deprivation & hypoxia) glioblastoma cells were led to autophagic cell death. Significantly increased expression of autophagy markers on FAT1 knockout and its combination with autophagic modulation substantiates the autophagic cell death in glioblastoma cells. Increased subcellular localization of LC3 validates the accumulation of autophagic vacuoles on FAT1 knockout in glioblastoma cells. Conclusively, our glioblastoma tumor data and in-vitro findings strongly suggest the role of FAT1 in negative regulating the expression of autophagy markers, thereby protecting the tumor cells from autophagic cell death.

Clinical trial identification

Editorial acknowledgement

Legal entity responsible for the study

Governance by Kunzang Chosdol, AIIMS, New Delhi, ICMR, New Delhi.

Funding

AIIMS, New Delhi, ICMR, New Delhi.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.